| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute pulmonary embolism following recent hospitalization or surgery
|
Shanafelt, Colby
|
|
|
52 |
1 |
p. 189-199
|
artikel
|
| 2 |
Analysis of the quality of reporting of randomized controlled trials in anticoagulant versus antiplatelet medication for venous thromboembolism prophylaxis as governed by the CONSORT statement
|
Beneki, Eirini
|
|
|
52 |
1 |
p. 138-147
|
artikel
|
| 3 |
Aqueous extract of Whitmania pigra Whitman ameliorates ferric chloride-induced venous thrombosis in rats via antioxidation
|
Li, Peng
|
|
|
52 |
1 |
p. 59-68
|
artikel
|
| 4 |
Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients
|
Degliuomini, Melanie
|
|
|
52 |
1 |
p. 209-213
|
artikel
|
| 5 |
Bivalirudin dosing during prolonged intermittent renal replacement therapy: a case report
|
Bohm, Nicole M.
|
|
|
52 |
1 |
p. 345-349
|
artikel
|
| 6 |
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
|
Wallvik, Niklas
|
|
|
52 |
1 |
p. 315-323
|
artikel
|
| 7 |
Bridge mechanical thrombectomy may be a better choice for acute large vessel occlusions
|
Zha, Mingming
|
|
|
52 |
1 |
p. 291-300
|
artikel
|
| 8 |
Cardiac pathophysiology in sickle cell disease
|
Gbotosho, Oluwabukola Temitope
|
|
|
52 |
1 |
p. 248-259
|
artikel
|
| 9 |
Clinical and sociodemographic factors associated with anticoagulant use for cancer associated venous thromboembolism
|
Schaefer, Jordan K.
|
|
|
52 |
1 |
p. 214-223
|
artikel
|
| 10 |
Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic
|
Matsushita, Kensuke
|
|
|
52 |
1 |
p. 95-104
|
artikel
|
| 11 |
Clinical outcomes of very elderly patients treated with ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism: a systematic review
|
Castillo-Perez, Mauricio
|
|
|
52 |
1 |
p. 260-271
|
artikel
|
| 12 |
Clinical validation of AggreGuide A-100 ADP, a novel assay for assessing the antiplatelet effect of oral P2Y12 antagonists
|
Gurbel, Paul A.
|
|
|
52 |
1 |
p. 272-280
|
artikel
|
| 13 |
Clopidogrel increases risk of pneumonia compared with aspirin in acute ischemic minor stroke patients
|
Yu, Zhangfeng
|
|
|
52 |
1 |
p. 301-307
|
artikel
|
| 14 |
Combining lung ultrasound and Wells score for diagnosing pulmonary embolism in critically ill COVID-19 patients
|
Zotzmann, Viviane
|
|
|
52 |
1 |
p. 76-84
|
artikel
|
| 15 |
Edoxaban, a direct oral factor Xa inhibitor, ameliorates coagulation, microvascular thrombus formation, and acute liver injury in a lipopolysaccharide-induced coagulopathy model in rats
|
Morishima, Yoshiyuki
|
|
|
52 |
1 |
p. 9-17
|
artikel
|
| 16 |
Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribing
|
Kampouraki, Emmanouela
|
|
|
52 |
1 |
p. 170-178
|
artikel
|
| 17 |
Evaluation of characteristics and dosing regimens in patients with new or recurrent thrombosis on apixaban and rivaroxaban
|
Dreucean, Diane
|
|
|
52 |
1 |
p. 161-169
|
artikel
|
| 18 |
Extended duration venous thromboembolism prophylaxis with betrixaban for patients re-admitted with venous thromboembolism
|
Fahmy, Monica
|
|
|
52 |
1 |
p. 22-29
|
artikel
|
| 19 |
Extracellular matrix collagen biomarkers levels in patients with chronic thromboembolic pulmonary hypertension
|
Pang, Wenyi
|
|
|
52 |
1 |
p. 48-58
|
artikel
|
| 20 |
FVII gene R353Q polymorphism and coronary heart disease: a meta-analysis including 3258 subjects
|
Li, Yan-yan
|
|
|
52 |
1 |
p. 324-330
|
artikel
|
| 21 |
Highlights from the American society of hematology conference 2020
|
Grover, Punita
|
|
|
52 |
1 |
p. 354-362
|
artikel
|
| 22 |
Incidence and risk factors for PTT prolongation in patients receiving low-dose unfractionated heparin thromboprophylaxis
|
Feinbloom, David
|
|
|
52 |
1 |
p. 331-337
|
artikel
|
| 23 |
Increased interest in acute pulmonary embolism in Italy during the COVID-19 pandemic: a google trends-based analysis
|
Roncon, Loris
|
|
|
52 |
1 |
p. 92-94
|
artikel
|
| 24 |
Internuclear ophthalmoplegia as an atypical presentation of lacunar stroke in CADASIL
|
Figueiredo, Carlos
|
|
|
52 |
1 |
p. 350-353
|
artikel
|
| 25 |
Lupus anticoagulant and mortality in patients hospitalized for COVID-19
|
Gazzaruso, Carmine
|
|
|
52 |
1 |
p. 85-91
|
artikel
|
| 26 |
Major bleeding complications in critically ill patients with COVID-19 pneumonia
|
Godier, Anne
|
|
|
52 |
1 |
p. 18-21
|
artikel
|
| 27 |
Management of warfarin-associated intracerebral hemorrhage before and after implementation of an order set and prospective pharmacist order verification
|
Varnes, Beth E.
|
|
|
52 |
1 |
p. 239-247
|
artikel
|
| 28 |
Massive intraperitoneal hemorrhage in patients with COVID-19: a case series
|
Reisi-Vanani, Vahid
|
|
|
52 |
1 |
p. 338-344
|
artikel
|
| 29 |
Mitochondria-DNA copy-number and incident venous thromboembolism among middle-aged women: a population-based cohort study
|
Nymberg, Peter
|
|
|
52 |
1 |
p. 148-157
|
artikel
|
| 30 |
Need for anticoagulation and use of direct oral anticoagulants in lung transplant recipients
|
Kao, Christina C.
|
|
|
52 |
1 |
p. 232-238
|
artikel
|
| 31 |
Occurrence of pulmonary embolism related to COVID-19
|
Hauguel-Moreau, Marie
|
|
|
52 |
1 |
p. 69-75
|
artikel
|
| 32 |
Outpatient management of patients presenting with venous thromboembolism: Retrospective cohort study at 11 community hospitals
|
Khatib, Rasha
|
|
|
52 |
1 |
p. 179-188
|
artikel
|
| 33 |
Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy
|
Piazza, Gregory
|
|
|
52 |
1 |
p. 281-290
|
artikel
|
| 34 |
Plasma levels of extracellular vesicles and the risk of post-operative pulmonary embolism in patients with primary brain tumors: a prospective study
|
Passamonti, Serena M.
|
|
|
52 |
1 |
p. 224-231
|
artikel
|
| 35 |
Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus
|
Plasín-Rodríguez, Miguel Angel
|
|
|
52 |
1 |
p. 30-41
|
artikel
|
| 36 |
Reasons for new patient warfarin referrals to an anticoagulant management service in 2019: a single institution experience
|
Sylvester, Katelyn W.
|
|
|
52 |
1 |
p. 158-160
|
artikel
|
| 37 |
SARS-CoV-2 infection and thrombotic complications: a narrative review
|
Moschonas, Iraklis C.
|
|
|
52 |
1 |
p. 111-123
|
artikel
|
| 38 |
Serotonin: a platelet hormone modulating cardiovascular disease
|
Rieder, Marina
|
|
|
52 |
1 |
p. 42-47
|
artikel
|
| 39 |
Small lipid core burden index in patients with stable angina pectoris is also associated with microvascular dysfunction: Insights from intracoronary electrocardiogram
|
Sato, Takao
|
|
|
52 |
1 |
p. 1-8
|
artikel
|
| 40 |
The experience of Hamad General Hospital collaborative anticoagulation clinic in Qatar during the COVID-19 pandemic
|
Abdallah, Ibtihal
|
|
|
52 |
1 |
p. 308-314
|
artikel
|
| 41 |
Ultrasound-assisted catheter-directed thrombolysis versus systemic anticoagulation alone for submassive pulmonary embolism
|
Kline, Theresa M.
|
|
|
52 |
1 |
p. 130-137
|
artikel
|
| 42 |
Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis
|
Kow, Chia Siang
|
|
|
52 |
1 |
p. 124-129
|
artikel
|
| 43 |
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?
|
Ruberto, Franco
|
|
|
52 |
1 |
p. 105-110
|
artikel
|
| 44 |
Working smarter, not harder: evaluating a population health approach to anticoagulation therapy management
|
Rossier, Connor
|
|
|
52 |
1 |
p. 200-208
|
artikel
|
Tijdschrift beschrijving